Back

Electrocardiographic predictors of haemodynamic benefit from biventricular pacing: the role of atrioventricular timing measures

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation therapy - conduction system pacing 1 Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speakers

Photo
Doctor Turja Chakraborty

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Photo
Doctor Ahran Arnold

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial.
Doctor J. Francisco Pascual (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
His bundle pacing implantation in octogenarian patients: a substudy of the PACE-CONDUCT trial
Doctor D. Stangl (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Temporal evolution of His bundle pacing thresholds: a sub-study of the PACE-CONDUCT trial
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular systolic pressure is an independent risk factor of all-cause death and inappropriate therapies in patients with implanted CRT-D
Doctor J. Machowicz (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy
Doctor D. Faccenda (Lugan, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation therapy - conduction system pacing 1

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Six-month echocardiographic follow-up of left bundle branch optimized cardiac resynchronization therapy (LOT-CRT) versus traditional CRT
thumbnail
Congress Presentation
Defining ECG imaging resynchronisation criteria for improved cardiac resynchronisation therapy in LBBB patients
thumbnail
Congress Presentation
Differences in cardiac resynchronisation therapy's response in patients with non-LBBB QRS complex morphology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources